ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,035,299 | +28.4% | 8,208 | 0.0% | 1.20% | +81.0% |
| Q2 2023 | $3,143,336 | +2.8% | 8,208 | 0.0% | 0.66% | -35.4% |
| Q1 2023 | $3,058,137 | -0.9% | 8,208 | 0.0% | 1.03% | -12.2% |
| Q4 2022 | $3,084,484 | +5.1% | 8,208 | 0.0% | 1.17% | +9.8% |
| Q3 2022 | $2,935,000 | -5.6% | 8,208 | 0.0% | 1.07% | +3.5% |
| Q2 2022 | $3,110,000 | -53.0% | 8,208 | -60.9% | 1.03% | -29.6% |
| Q1 2022 | $6,624,000 | -21.9% | 21,009 | -12.5% | 1.46% | -13.0% |
| Q4 2021 | $8,480,000 | – | 24,020 | – | 1.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |